UK secures 2 million more doses of Moderna’s Covid-19 vaccine | World News - Hindustan Times
close_game
close_game

UK secures 2 million more doses of Moderna’s Covid-19 vaccine

ByReuters | Posted by Deepali Sharma
Nov 29, 2020 10:45 AM IST

Moderna’s experimental vaccine is 94.5% effective in preventing Covid-19 based on interim data from a late-stage trial.

Britain has secured two million doses of Moderna Inc’s Covid-19 vaccine candidate, to be available in Europe as early as the spring, the government said on Sunday, in addition to the 5 million doses it secured from the US company two weeks ago.

Britain now has access to enough doses of Moderna’s vaccine candidate for around 3.5 million people.(Reuters)
Britain now has access to enough doses of Moderna’s vaccine candidate for around 3.5 million people.(Reuters)

Click here for complete coverage of Covid-19

Hindustan Times - your fastest source for breaking news! Read now.

The new deal came a day after Prime Minister Boris Johnson named Nadhim Zahawi, a junior business minister, to be minister responsible for the deployment of Covid-19 vaccines.

Britain now has access to enough doses of Moderna’s vaccine candidate for around 3.5 million people. Overall, it has access to 357 million doses of vaccines from seven developers, according to government statement.

“With a wide range of vaccine candidates in our portfolio, we stand ready to deploy a vaccine should they receive approval from our medicines regulator, starting with those who will benefit most,” health minister Matt Hancock said in the statement.

Moderna’s experimental vaccine is 94.5% effective in preventing Covid-19 based on interim data from a late-stage trial.

Deliveries to Britain could begin as early as the spring, if the vaccine meets the standards of the Medicines and Healthcare products Regulatory Agency.

Also Read | ‘Need to follow Covid-19 protocol even after vaccine is available, masks here to stay’: ICMR chief

Britain has also ordered 40 million doses of a vaccine developed by Germany’s BioNTech SE and Pfizer Inc of the United States, which has been found to be 95% effective in preventing the spread of the new coronavirus.

The UK regulator is set to approve the BioNTech-Pfizer vaccine this week, and deliveries will begin within hours of the authorisation, the Financial Times said on Saturday.

Britain has also secured 100 million doses of the vaccine developed by AstraZeneca PLC and Oxford University and has targeted a rollout to begin before Christmas.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now!

Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On